Navigation Links
Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
Date:4/26/2013

NANJING, China, April 26, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2013 on Thursday, May 9, 2013, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Thursday, May 9, at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:International toll: 

+65.6723.9381United States toll-free: 

+1.866.519.4004United States toll: 

+1.718.354.1231China Domestic toll: 

800.819.0121 China Domestic mobile toll: 

400.620.8038 Hong Kong toll: 

+852.2475.0994Please ask to be connected to Q1 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 58031483.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:

+1. 855.452.5696United States toll:

+1. 646.254.3697The passcode for replay participants is 58031483. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com.Investor and Media Contacts: Email: ir@simcere.com In Nanjing:Jie Liu D'EliaVice PresidentSimcere Pharmaceutical GroupTel: 86-25-8556-6666*8857In the United States:Cindy Zheng

Brunswick Group

Tel: 1-212-333-3810In Beijing: Yue YuBrunswick GroupTel: 86-10-5960-8 

 

 


'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
2. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
3. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Legal Counsel
4. Simcere Pharmaceutical Group Announces Receipt of "Going Private" Proposal
5. Simcere Pharmaceutical Group Reports Preliminary Unaudited Fourth Quarter And Full Year 2012 Results
6. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
7. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
8. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
9. Simcere Pharmaceutical Group to Announce Third Quarter 2012 Financial Results on Thursday, November 15, 2012
10. Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
11. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016   HeartWare International, Inc ... call and webcast to discuss its financial results for ... on Thursday, February 25, 2016 at 8:00 a.m. ET. ... to the conference call and webcast.  On the conference ... results, highlights from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... AUSTIN, Texas , Feb. 12, 2016 ... Institute for Robotic Surgery at St. David,s North Austin ... the da Vinci ® Xi ® Surgical ... ® 7000dV. Thiru Lakshman , M.D., ... performed a total proctocolectomy utilizing Integrated Table Motion technology, ...
(Date:2/12/2016)... North Carolina , 12 februari 2016 ... Inc. (AAI/CML), een toonaangevende leverancier van productie ... en biotechnologische industrieën, kondigt vandaag een uitbreiding ... mogelijkheden op haar locatie in ... vraag heeft geleid tot meerdere recente investeringen. ...
Breaking Medicine Technology:
(Date:2/14/2016)... ... February 14, 2016 , ... ... eating disorders professionals near their residence. The nature of the illnesses requires ongoing ... care or time allotted at work to make traditional appointments. These people struggle ...
(Date:2/13/2016)... ... , ... Hidden Cypress in Sun City is the place to be on March 3rd to ... Weniger will be hosting this educational seminar from 5:30 p.m. – 7:00 p.m. Exciting ... pricing on offers. In addition, prizes will be given away and light refreshments will be ...
(Date:2/13/2016)... ... ... Many individuals looking to lead a healthy lifestyle have decreased carbohydrate consumption and ... Fitness has delved into this niche allowing those giving up their beloved pasta a ... 30 grams of protein and only 7 grams of carbohydrates per 50 gram serving--a ...
(Date:2/13/2016)... ... February 13, 2016 , ... In its newly ... vein visualization technology should be used to ensure patient safety when placing an ... INS Standards mandate the use of vein visualization technology in patients with difficult ...
(Date:2/13/2016)... ... , ... In the early or “honeymoon” stage of a relationship, couples strive ... their way to be romantic, and may exaggerate a strength or two in an ... profile. , A recent study from Queendom.com , however, suggests that new ...
Breaking Medicine News(10 mins):